City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

Cancer screening guidance from City of Hope experts

August 16, 2019 | Samantha Bonar

August 16 is National Cancer Screening Day for breast, cervical and colorectal cancer. The day is an effort to increase awareness and education for breast, cervical and colorectal cancers.

City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer

August 15, 2019 | Letisia Marquez

Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.

Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas

August 14, 2019 | Jenny Peters

City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.

City of Hope lauded for lung, colon cancer surgery

August 12, 2019 | Abe Rosenberg

U.S. News & World Report, which recently named City of Hope the best cancer facility in the West, singled out the colon cancer surgery and lung cancer surgery divisions as “high performing.”

New ‘liquid biopsy’ blood test could improve breast cancer diagnostics

August 7, 2019 | Letisia Marquez

Developed by TGen and partners, the test could help avoid unnecessary surgeries and enable physicians to continuously monitor cancer. It works by measuring tiny particles of tumor DNA circulating in a patient's bloodstream.

First in the nation: City of Hope to offer experimental T cell drug for liver cancer patients

August 5, 2019 | Zen Vuong

An ongoing clinical study in China on the drug showed liver tumor shrinkage, regression of metastatic tumors and fewer side effects than in other T cell clinical trials.

City of Hope is fourth in the nation in patient experience, according to U.S. News & World Report.

August 1, 2019 | Samvel Lazaryev

City of Hope ranked fourth in the country out of 885 hospitals surveyed in patient satisfaction according to U.S. News & World Report. Measurements included communication with and responsiveness of hospital staff, cleanliness and quietness of the hospital environment, pain management and communication about medicines.

Caitlin's journey: Lymphoma patient gets fresh start with CAR T

July 31, 2019 | Abe Rosenberg

Diagnosed with a rare, fast-growing blood cancer and ineligible for a lifesaving stem cell transplant after failing chemotherapy, treatment with a breakthrough CAR T drug called Yescarta was Caitlin Buchanan's best hope for survival.

New developments in sarcoma research and treatment

July 31, 2019 | Malcolm Bedell

While a rare and challenging cancer, several recent breakthroughs have shown potential to extend survival and improve quality of life for sarcoma patients.

U.S. News: City of Hope Is Best Cancer Hospital in the West

July 29, 2019 | Letisia Marquez

City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.